Solara Active Pharma Sciences reports consolidated net loss of Rs 17.43 crore in the December 2025 quarter
(06 Feb 2026)

Back
Net loss of Solara Active Pharma Sciences reported to Rs 17.43 crore in the quarter ended December 2025 as against net profit of Rs 8.09 crore during the previous quarter ended December 2024. Sales rose 16.21% to Rs 349.00 crore in the quarter ended December 2025 as against Rs 300.31 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales349.00300.31 16
OPM %10.7019.21 -
PBDT14.8932.63 -54
PBT-10.688.09 PL
NP-17.438.09 PL

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew